Viewing Study NCT00280969


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-04-09 @ 12:28 PM
Study NCT ID: NCT00280969
Status: COMPLETED
Last Update Posted: 2015-03-30
First Post: 2006-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
Sponsor: International Medical Center of Japan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module